Evidence map›Paper›PMID 30559293›Full record

ArticleThe Journal of biological chemistry2019

Luminescence-activated nucleotide cyclase regulates spatial and temporal cAMP synthesis.

Nyla Naim, Alex D White, Jeff M Reece, Mamta Wankhede, Xuefeng Zhang, Jean-Pierre Vilardaga, Daniel L Altschuler

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Soluble cyclase-mediated nuclear cAMP synthesis is sufficient for cell proliferation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. CAP1 binds and activates adenylyl cyclase in mammalian cells.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Bioluminescence-Driven Optogenetics.Life (Basel, Switzerland) · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nyla NaimDepartment of Pharmacology and Chemical Biology, Pittsburgh, Pennsylvania 15261; Molecular Pharmacology Training Program, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Alex D WhiteDepartment of Pharmacology and Chemical Biology, Pittsburgh, Pennsylvania 15261; Molecular Pharmacology Training Program, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Jeff M ReeceDepartment of Pharmacology and Chemical Biology, Pittsburgh, Pennsylvania 15261.
Mamta WankhedeDepartment of Pharmacology and Chemical Biology, Pittsburgh, Pennsylvania 15261.
Xuefeng ZhangDepartment of Pharmacology and Chemical Biology, Pittsburgh, Pennsylvania 15261.
Jean-Pierre VilardagaDepartment of Pharmacology and Chemical Biology, Pittsburgh, Pennsylvania 15261.
Daniel L AltschulerDepartment of Pharmacology and Chemical Biology, Pittsburgh, Pennsylvania 15261. Electronic address: altschul@pitt.edu.
University of Pittsburgh · US

Funding

Structure and function of PTH class B GPCRR01DK116780 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ivet Bahar, Jean-Pierre Vilardaga · 2018 to 2026
$4.2M
PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIENCEST32GM008424 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PAGANO, PATRICK J · 1994 to 2019
$3.4M
Functional Polarity of PTH Receptor Signaling: Cellular and Molecular MechanismsR01DK111427 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FRIEDMAN, PETER A, VILARDAGA, JEAN-PIERRE · 2017 to 2020
$2.4M
Structural and Functional Mechanisms of PTH-Receptor SignalingR01DK102495 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CALERO, GUILLERMO ALBERTO, GARDELLA, THOMAS J · 2014 to 2017
$2.0M
Role of soluble adenylyl cyclase in TSH biologyR01GM130612 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALTSCHULER, DANIEL L · 2019 to 2022
$1.7M
NIDDK NIH HHS R01 DK102495NIDDK NIH HHS R01 DK111427NIDDK NIH HHS R01 DK116780NIGMS NIH HHS R01 GM130612NIGMS NIH HHS T32 GM008424
6 · The paper itself

Abstract

cAMP is a ubiquitous second messenger that regulates cellular proliferation, differentiation, attachment, migration, and several other processes. It has become increasingly evident that tight regulation of cAMP accumulation and localization confers divergent yet specific signaling to downstream pathways. Currently, few tools are available that have sufficient spatial and temporal resolution to study location-biased cAMP signaling. Here, we introduce a new fusion protein consisting of a light-activated adenylyl cyclase (bPAC) and luciferase (nLuc). This construct allows dual activation of cAMP production through temporally precise photostimulation or chronic chemical stimulation that can be fine-tuned to mimic physiological levels and duration of cAMP synthesis to trigger downstream events. By targeting this construct to different compartments, we show that cAMP produced in the cytosol and nucleus stimulates proliferation in thyroid cells. The bPAC-nLuc fusion construct adds a new reagent to the available toolkit to study cAMP-regulated processes in living cells.

Indexed as

LuminescenceAdenylyl CyclasesAnimalsCell ProliferationCells, CulturedCyclic AMPEnzyme ActivationHEK293 CellsHumansLightLuciferasesRatsAdenylyl CyclasesCyclic AMPLuciferasesbioluminescencebPACcell proliferationcompartmentalizationcyclic AMP (cAMP)fluorescence resonance energy transfer (FRET)microdomainsnano-luciferaseoptogeneticssecond messengersignalingthyroid

Identifiers

PMID30559293
PMCPMC6349105
OpenAlexW2903611023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.